Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza
Conditions
Interventions
Nitazoxanide
Oseltamivir
+2 more
Locations
167
United States
Influence Study Site
Birmingham, Alabama, United States
Influence Study Site
Dothan, Alabama, United States
Influence Study Site
Hoover, Alabama, United States
Influence Study Site
Mobile, Alabama, United States
Influence Study Site
Mesa, Arizona, United States
Influence Study Site
Mesa, Arizona, United States
Start Date
March 1, 2013
Primary Completion Date
March 1, 2015
Completion Date
April 16, 2015
Last Updated
March 29, 2018
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
Romark Laboratories L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions